Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Change in Inventory: 2021-2024

Historic Change in Inventory for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Dec 2024 value amounting to $3.2 million.

  • Mirum Pharmaceuticals' Change in Inventory rose 28.35% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year increase of 270.93%. This contributed to the annual value of $3.2 million for FY2024, which is 225.05% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Change in Inventory of $3.2 million as of FY2024, which was up 225.05% from $974,000 recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Change in Inventory registered a high of $3.4 million during FY2022, and its lowest value of $495,000 during FY2021.
  • Its 3-year average for Change in Inventory is $2.5 million, with a median of $3.2 million in 2024.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 596.57% in 2022, then slumped by 71.75% in 2023.
  • Mirum Pharmaceuticals' Change in Inventory (Yearly) stood at $495,000 in 2021, then surged by 596.57% to $3.4 million in 2022, then tumbled by 71.75% to $974,000 in 2023, then soared by 225.05% to $3.2 million in 2024.